- Home
- MDBH vs PEPG Comparison
MDBH vs PEPG Comparison
Compare MDBH & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- PEPG
- Stock Information
- Founded
- MDBH 1997
- PEPG 2018
- Country
- MDBH United States
- PEPG United States
- Employees
- MDBH N/A
- PEPG N/A
- Industry
- MDBH
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- PEPG Health Care
- Exchange
- MDBH Nasdaq
- PEPG Nasdaq
- Market Cap
- MDBH 39.3M
- PEPG 52.4M
- IPO Year
- MDBH 2023
- PEPG 2022
- Fundamental
- Price
- MDBH $3.80
- PEPG $1.46
- Analyst Decision
- MDBH
- PEPG Buy
- Analyst Count
- MDBH 0
- PEPG 3
- Target Price
- MDBH N/A
- PEPG $7.67
- AVG Volume (30 Days)
- MDBH 6.0K
- PEPG 224.5K
- Earning Date
- MDBH 05-12-2025
- PEPG 05-08-2025
- Dividend Yield
- MDBH N/A
- PEPG N/A
- EPS Growth
- MDBH N/A
- PEPG N/A
- EPS
- MDBH 0.84
- PEPG N/A
- Revenue
- MDBH $3,574,131.00
- PEPG N/A
- Revenue This Year
- MDBH N/A
- PEPG N/A
- Revenue Next Year
- MDBH N/A
- PEPG N/A
- P/E Ratio
- MDBH $4.51
- PEPG N/A
- Revenue Growth
- MDBH N/A
- PEPG N/A
- 52 Week Low
- MDBH $3.61
- PEPG $0.88
- 52 Week High
- MDBH $12.00
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- MDBH 33.72
- PEPG 48.32
- Support Level
- MDBH $4.08
- PEPG $1.40
- Resistance Level
- MDBH $5.06
- PEPG $1.73
- Average True Range (ATR)
- MDBH 0.23
- PEPG 0.17
- MACD
- MDBH -0.04
- PEPG 0.01
- Stochastic Oscillator
- MDBH 13.10
- PEPG 32.50
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.